In several diseases involving immune dysregulation including obesity, DM and its complications, the activation of toll-like receptors (TLRs), particularly toll-like receptor 4 (TLR4), among many isoforms showed to garner great therapeutic interest, thus its pharmacological manipulation received interest in recent years [108]. Here, TLR4 is linked to obesity due to melanocortin 4 receptor deficiency.